Publications

Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo

 60
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo

Tags:

Previous Article

Liver identified as driver of body wasting in cancer

Next Article

Combination antiretroviral therapy!

Related Posts

Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function

Co-opting templated aggregation to degrade pathogenic t...

 76

Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)

Lipotoxicity-driven metabolic dysfunction-associated st...

 83

Molecular mechanism of ultrafast transport by plasma membrane Ca2+-ATPases

Molecular mechanism of ultrafast transport by plasma me...

 46